Qinghai Spring Medicinal Resources Technology Company Overview

  • Status
  • Public

  • Employees
  • 159

Employees

  • Stock Symbol
  • 600381

Stock Symbol

  • Share Price
  • $0.68
  • (As of Friday Closing)

Qinghai Spring Medicinal Resources Technology Company General Information

Description

Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.

Contact Information

Formerly Known As
Qinghai Sunshiny Mining
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • South Road, New Hope Building, No. 2102
  • Chengdu, Wuhou District
  • China
+86 400
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • South Road, New Hope Building, No. 2102
  • Chengdu, Wuhou District
  • China
+86 400

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qinghai Spring Medicinal Resources Technology Company Stock Performance

As of 13-Jun-2025, Qinghai Spring Medicinal Resources Technology Company’s stock price is $0.68. Its current market cap is $402M with 587M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.68 $0.65 $0.25 - $0.69 $402M 587M 9.7M -$0.04

Qinghai Spring Medicinal Resources Technology Company Financials Summary

As of 31-Mar-2025, Qinghai Spring Medicinal Resources Technology Company has a trailing 12-month revenue of $37.4M.

In Thousands,
USD
TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 348,791 275,394 619,214 1,012,347
Revenue 37,379 37,665 30,230 23,785
EBITDA (23,906) (23,968) (32,960) (37,740)
Net Income (22,615) (27,701) (37,861) (42,698)
Total Assets 154,052 159,489 191,760 225,998
Total Debt 1,465 1,617 2,632 710
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Qinghai Spring Medicinal Resources Technology Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Qinghai Spring Medicinal Resources Technology Company‘s full profile, request access.

Request a free trial

Qinghai Spring Medicinal Resources Technology Company Patents

Qinghai Spring Medicinal Resources Technology Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4353263-A1 Use of composition of alcohol and cooling agent in regulating sexual function, protecting cardiovascular and cerebrovascular system, promoting hepatocyte regeneration, fighting against tumor, and improving immunity and sleep quality Pending 02-Jun-2021
US-20240252453-A1 Use of composition of alcohol and cooling agent in regulating sexual functions, protecting cardiovascular and cerebrovascular systems, promoting regeneration of liver cells, preventing and/or treating tumors, and improving immunity and sleep quality Pending 02-Jun-2021
EP-4353263-A4 Use of composition of alcohol and cooling agent in regulating sexual function, protecting cardiovascular and cerebrovascular system, promoting hepatocyte regeneration, fighting against tumor, and improving immunity and sleep quality Pending 02-Jun-2021 A61K31/16

Qinghai Spring Medicinal Resources Technology Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qinghai Spring Medicinal Resources Technology Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Media

Industry

Rank

Percentile

Advertising

Subindustry

Rank

Percentile

To view Qinghai Spring Medicinal Resources Technology Company’s complete esg history, request access »

Qinghai Spring Medicinal Resources Technology Company FAQs

  • Where is Qinghai Spring Medicinal Resources Technology Company headquartered?

    Qinghai Spring Medicinal Resources Technology Company is headquartered in Chengdu, China.

  • What is the size of Qinghai Spring Medicinal Resources Technology Company?

    Qinghai Spring Medicinal Resources Technology Company has 159 total employees.

  • What industry is Qinghai Spring Medicinal Resources Technology Company in?

    Qinghai Spring Medicinal Resources Technology Company’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Qinghai Spring Medicinal Resources Technology Company a private or public company?

    Qinghai Spring Medicinal Resources Technology Company is a Public company.

  • What is Qinghai Spring Medicinal Resources Technology Company’s stock symbol?

    The ticker symbol for Qinghai Spring Medicinal Resources Technology Company is 600381.

  • What is the current stock price of Qinghai Spring Medicinal Resources Technology Company?

    As of 13-Jun-2025 the stock price of Qinghai Spring Medicinal Resources Technology Company is $0.68.

  • What is the current market cap of Qinghai Spring Medicinal Resources Technology Company?

    The current market capitalization of Qinghai Spring Medicinal Resources Technology Company is $402M.

  • What is Qinghai Spring Medicinal Resources Technology Company’s current revenue?

    The trailing twelve month revenue for Qinghai Spring Medicinal Resources Technology Company is $37.4M.

  • What is Qinghai Spring Medicinal Resources Technology Company’s annual earnings per share (EPS)?

    Qinghai Spring Medicinal Resources Technology Company’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »